Stingray Therapeutics

Developer of immunotherapeutics for treating cancer

placeHouston, Texas, United States calendar_todayFounded 2018 groups6 employees language stingraytx.com

Innovation

8 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 163 times.

YearFilings
20191
20203
20213
20225
20235
20242
20252
20261

Investor mix

4 investors on record; lead investors include Health Wildcatters.

Investor typeCountShare
Venture capital250%
Accelerator & incubator125%
Other / undisclosed125%
Coming soon